Unc18-1 Antibodies

Santa Cruz Biotechnology features a diverse variety of Unc18-1 monoclonal antibodies for research applications. Unc18-1 Antibodies are validated for multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Unc18-1, also known as Munc18-1, is a key protein involved in the regulation of neurotransmitter release and synaptic vesicle trafficking. It plays a vital role in the docking and fusion of synaptic vesicles with the presynaptic membrane, making it essential for proper neuronal communication. Understanding Unc18-1 function is crucial for elucidating mechanisms underlying various neurological disorders. Researchers can explore molecular interactions between Unc18-1 and its binding partners in synaptic vesicle release. Advanced visualization techniques using specific markers help reveal Unc18-1 localization patterns in neuronal cells. Investigating Unc18-1 expression levels provides valuable information about synaptic plasticity and neurotransmission. Studies focusing on Unc18-1 contribute significantly to understanding synaptic dysfunction in neurological conditions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance neuroscience research and contribute to the understanding of neurological disease mechanisms.